CenterBook Partners LP Has $1.49 Million Stock Holdings in Tenet Healthcare Co. (NYSE:THC)

CenterBook Partners LP cut its stake in Tenet Healthcare Co. (NYSE:THC - Free Report) by 15.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 11,800 shares of the company's stock after selling 2,095 shares during the quarter. CenterBook Partners LP's holdings in Tenet Healthcare were worth $1,490,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of the stock. WR Wealth Planners LLC boosted its position in shares of Tenet Healthcare by 2,836.4% during the fourth quarter. WR Wealth Planners LLC now owns 323 shares of the company's stock valued at $41,000 after buying an additional 312 shares during the last quarter. Smartleaf Asset Management LLC increased its position in shares of Tenet Healthcare by 30.5% during the 4th quarter. Smartleaf Asset Management LLC now owns 471 shares of the company's stock valued at $59,000 after purchasing an additional 110 shares during the last quarter. Kestra Investment Management LLC bought a new stake in Tenet Healthcare in the 4th quarter valued at $60,000. Wilmington Savings Fund Society FSB raised its stake in shares of Tenet Healthcare by 1,352.8% in the fourth quarter. Wilmington Savings Fund Society FSB now owns 523 shares of the company's stock valued at $66,000 after acquiring an additional 487 shares during the period. Finally, Spire Wealth Management raised its holdings in shares of Tenet Healthcare by 19.5% in the 4th quarter. Spire Wealth Management now owns 558 shares of the company's stock valued at $70,000 after purchasing an additional 91 shares in the last quarter. 95.44% of the stock is owned by institutional investors and hedge funds.

Remove Ads

Tenet Healthcare Price Performance

Tenet Healthcare stock traded up $1.54 during mid-day trading on Wednesday, hitting $122.45. 385,916 shares of the company traded hands, compared to its average volume of 1,508,402. The company has a debt-to-equity ratio of 2.25, a quick ratio of 1.70 and a current ratio of 1.78. Tenet Healthcare Co. has a one year low of $90.03 and a one year high of $171.20. The stock has a fifty day moving average price of $128.99 and a 200-day moving average price of $139.03. The stock has a market cap of $11.65 billion, a price-to-earnings ratio of 3.80, a price-to-earnings-growth ratio of 1.02 and a beta of 1.77.

Tenet Healthcare (NYSE:THC - Get Free Report) last issued its earnings results on Wednesday, February 12th. The company reported $3.44 earnings per share for the quarter, topping the consensus estimate of $2.95 by $0.49. Tenet Healthcare had a net margin of 15.48% and a return on equity of 21.88%. On average, equities analysts predict that Tenet Healthcare Co. will post 12.24 earnings per share for the current fiscal year.

Insider Transactions at Tenet Healthcare

In other Tenet Healthcare news, Director J Robert Kerrey sold 9,525 shares of Tenet Healthcare stock in a transaction on Tuesday, March 11th. The shares were sold at an average price of $125.43, for a total value of $1,194,720.75. Following the transaction, the director now directly owns 27,378 shares in the company, valued at approximately $3,434,022.54. The trade was a 25.81 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 0.93% of the company's stock.

Analyst Upgrades and Downgrades

THC has been the topic of several recent research reports. TD Cowen assumed coverage on Tenet Healthcare in a report on Wednesday, February 26th. They set a "buy" rating and a $175.00 target price on the stock. Robert W. Baird restated a "neutral" rating and issued a $137.00 price target (down previously from $153.00) on shares of Tenet Healthcare in a research report on Tuesday. Cantor Fitzgerald reissued an "overweight" rating and issued a $177.00 price target on shares of Tenet Healthcare in a report on Thursday, February 13th. Guggenheim initiated coverage on shares of Tenet Healthcare in a report on Wednesday, April 9th. They issued a "buy" rating and a $165.00 target price on the stock. Finally, StockNews.com upgraded shares of Tenet Healthcare from a "hold" rating to a "buy" rating in a report on Thursday, March 13th. Five equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $165.44.

Tenet Healthcare Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.